120 filings
4
ACXP
Acurx Pharmaceuticals Inc
3 Apr 24
Acurx Pharmaceuticals / DAVID P LUCI ownership change
9:56pm
4
ACXP
Acurx Pharmaceuticals Inc
3 Apr 24
Acurx Pharmaceuticals / Robert G. Shawah ownership change
9:56pm
4
ACXP
Acurx Pharmaceuticals Inc
3 Apr 24
Acurx Pharmaceuticals / ROBERT J DELUCCIA ownership change
9:55pm
FWP
ACXP
Acurx Pharmaceuticals Inc
2 Apr 24
Free writing prospectus
7:31am
S-1/A
ACXP
Acurx Pharmaceuticals Inc
IPO registration (amended)
29 Mar 24
4:58pm
8-K
ACXP
Acurx Pharmaceuticals Inc
18 Mar 24
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:15pm
S-1
ACXP
Acurx Pharmaceuticals Inc
IPO registration
18 Mar 24
4:06pm
S-8
ACXP
Acurx Pharmaceuticals Inc
15 Mar 24
Registration of securities for employees
4:33pm
10-K
2023 FY
ACXP
Acurx Pharmaceuticals Inc
Annual report
15 Mar 24
4:05pm
SC 13G/A
ACXP
Acurx Pharmaceuticals Inc
14 Feb 24
Acurx Pharmaceuticals / ARMISTICE CAPITAL ownership change
2:39pm
4
ACXP
Acurx Pharmaceuticals Inc
22 Jan 24
Acurx Pharmaceuticals / Carl Sailer ownership change
6:15am
4
ACXP
Acurx Pharmaceuticals Inc
4 Jan 24
Acurx Pharmaceuticals / ROBERT J DELUCCIA ownership change
4:26pm
4
ACXP
Acurx Pharmaceuticals Inc
4 Jan 24
Acurx Pharmaceuticals / DAVID P LUCI ownership change
4:24pm
8-K
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
424B5
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Prospectus supplement for primary offering
4:49pm
8-K
ACXP
Acurx Pharmaceuticals Inc
14 Nov 23
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
4:05pm
10-Q
2023 Q3
ACXP
Acurx Pharmaceuticals Inc
Quarterly report
13 Nov 23
12:00am
8-K
ACXP
Acurx Pharmaceuticals Inc
3 Nov 23
Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection
4:05pm
8-K
ACXP
Acurx Pharmaceuticals Inc
2 Oct 23
Other Events
4:41pm
8-K
ACXP
Acurx Pharmaceuticals Inc
14 Aug 23
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update
7:10am